Popoola Victor O, Lau Brandyn D, Tan Esther, Shaffer Dauryne L, Kraus Peggy S, Farrow Norma E, Hobson Deborah B, Aboagye Jonathan K, Streiff Michael B, Haut Elliott R
Division of Acute Care Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, Baltimore, MD.
Am J Health Syst Pharm. 2018 Mar 15;75(6):392-397. doi: 10.2146/ajhp161057.
Results of a study to characterize patterns of nonadministration of medication doses for venous thromboembolism (VTE) prevention among hospitalized patients are presented.
The electronic records of all patients admitted to 4 floors of a medical center during a 1-month period were examined to identify patients whose records indicated at least 1 nonadministered dose of medication for VTE prophylaxis. Proportions of nonadministered doses by medication type, intended route of administration, and VTE risk categorization were compared; reasons for nonadministration were evaluated.
Overall, 12.7% of all medication doses prescribed to patients in the study cohort ( = 75) during the study period (857 of 6,758 doses in total) were not administered. Nonadministration of 1 or more doses of VTE prophylaxis medication was nearly twice as likely for subcutaneous anticoagulants than for all other medication types (231 of 1,112 doses [20.8%] versus 626 of 5,646 doses [11.2%], < 0.001). For all medications prescribed, the most common reason for nonadministration was patient refusal (559 of 857 doses [65.2%]); the refusal rate was higher for subcutaneous anticoagulants than for all other medication categories (82.7% versus 58.8%, < 0.001). Doses of antiretrovirals, immunosuppressives, antihypertensives, psychiatric medications, analgesics, and antiepileptics were less commonly missed than doses of electrolytes, vitamins, and gastrointestinal medications.
Scheduled doses of subcutaneous anticoagulants for hospitalized patients were more likely to be missed than doses of all other medication types.
呈现一项关于住院患者预防静脉血栓栓塞(VTE)时未给药剂量模式的研究结果。
检查了某医疗中心4个楼层在1个月期间所有入院患者的电子记录,以确定其记录显示至少有1剂预防VTE的药物未给药的患者。比较了按药物类型、预期给药途径和VTE风险分类的未给药剂量比例;评估了未给药的原因。
总体而言,在研究期间,研究队列中的患者(n = 75)所开的所有药物剂量中有12.7%(总共6758剂中的857剂)未给药。皮下抗凝剂未给药1剂或更多剂预防VTE药物的可能性几乎是所有其他药物类型的两倍(1112剂中的231剂[20.8%]对5646剂中的626剂[11.2%],P < 0.001)。对于所有开出的药物,未给药的最常见原因是患者拒绝(857剂中的559剂[65.2%]);皮下抗凝剂的拒绝率高于所有其他药物类别(82.7%对58.8%,P < 0.001)。抗逆转录病毒药物、免疫抑制剂、抗高血压药物、精神药物、镇痛药和抗癫痫药物的剂量比电解质、维生素和胃肠道药物的剂量更少被漏用。
住院患者皮下抗凝剂的预定剂量比所有其他药物类型的剂量更有可能被漏用。